The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work +972 3 695 2268
Fax +972 3 695 1120
Revohot, Tel Aviv

Adv Richard Luthi

Work +972 (3) 695 2268

Work Department

Intellectual Property


Managing Partner


Richard heads the firm’s practice. He is considered to be one of Israel’s premier IP litigators, and he leads the Luthi+Co. team in most major cases.

Richard studied law at the University of Southampton in England, where he was awarded the Winston Churchill prize for best academic performance. In 1986 he founded Luthi+Co., which under his leadership quickly grew to become one of Israel’s leading Intellectual Property firms.

Over the past 30 years, Richard has been lead counsel in countless Intellectual Property cases, including most of the major Intellectual Property cases litigated in Israel. He has played a major role in establishing Israel’s Intellectual Property jurisprudence.

Richard specializes in thinking outside the box, and under his leadership Luthi+Co. have developed an international practice managing and advising multinational and domestic clients on international litigation. Richard has also advised and represented the research based pharmaceutical industry in discussions with the Government and at the Knesset (The Israeli Parliament).

Richard has a record of public service and has served as a member of several governmental committees established to update and amend Intellectual Property legislation. To teach the next generation of Intellectual Property Attorneys in Israel, Richard has served as adjacent Professor of Law at Haifa University 2010-2012, where he taught Patent Law, and since 2016 is an adjacent Professor at the Hebrew University in Jerusalem where he teaches advanced Patent Law.

Together with partner Christopher Brice, Richard was invited to contribute the chapter on the “Protection of Inventions in Medicinal Chemistry” in the renowned textbook “The Practice of Medicinal Chemistry” (edited by C. Wermouth, 4th edition, 2015), which has garnered much praise from scientists and lawyers.


Hebrew, English


Israel Bar Association; AIPPI; INTA; Israel Copyright Association; ALAI


LL.B., Hons., 1980, University of Southampton, England;
Recipient, Winston Churchill Memorial Prize for Best Academic Performance


Intellectual property: disputes

Within: Intellectual property: disputes

Luthi+Webb has experience in complex trade mark and copyright litigation, but is particularly standout in patent disputes, where the team is involved in some of the highest-profile claims in Israel. The team is led by Richard Luthi, who is considered by his peers to be one of the very best IP litigators in the country. Luthi is acting for Millennium Pharmaceuticals (Takeda) in relation to a patent infringement dispute against several Israeli generic drug companies, and also acted for Johnson & Johnson in defence of a patent opposition filed by Teva. In addition, Luthi's team successfully represented Mapi Pharma in a patent opposition filed by Teva regarding Mapi's use of a basic ingredient in Teva's drug, Copaxone. The group is also representing the Knesset, various MPs, and the Speaker of the Knesset in a copyright infringement case initiated by FLASH90, a photojournalism agency. Other key contacts include Martin Binnes, who also has expertise in the pharmaceuticals sector, and Daniel Lerner, who has experience in patent litigation and is engaged by Israel Aerospace Industries and Albemarle Corporation.

[back to top]

Back to index

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

    Accredited investor funding platforms for innovative tech scale-ups offer more choice and without having to commit a large chunk of capital upfront, the risk is diluted.
  • Perhaps the QuadragaCX Story Will Have a Happy Ending

    While there are the aficionados who will say that cryptocurrencies will free us of the chains of the global financial institutions, on the occasions when the world of cryptocurrencies intersects with the world in which most of us live, the news is generally bleak. While you may not know one side of a Bitcoin from the other, you probably know that its value has crashed over the last 13 months, you may even have heard about some of some of the larger cryptohacks (that is computer heists through which digital currencies belonging to investors are stolen from crypto trading exchanges). And over the last week or so, you may have read on mainstream news sites about the death of Gerald Cotton the CEO of Canada’s largest cryptoexchange QuadragaCX. The death of the CEO of a company that few had previously heard of, was news of course, because in his passing he had taken the passwords to the accounts of his customers with him. The result of this being that about $140 million of their money was stuck somewhere between this world and the celestial ether in which Mr. Cotton now resides. Of course, it wasn’t quite told like that. We were fed terms such as “private keys,” lack of “multi-signature protection,” “cold storage wallets” and more readily understandable – “cryptofraud”. Again!
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
  • Spring is coming for real estate registration in Israel

    Israel may be the “Start-up Nation” and a world-renowned center of technological innovation, yet for many years the procedures and conduct of the Israeli Land Registry have been trapped in the past.

    Israeli hi-tech and its sources of funding have grown and diversified tremendously since the bubble burst in 2001 and over the last decade since the height of the financial crisis in 2007-2008.

    Nondiscrimination has been the neglected stepchild of the FRAND commitment. Patent owners participating in standards organizations typically commit to license their technology on “fair, reasonable, and nondiscriminatory (“FRAND”) terms.”
  • Crash Course on Non-Disclosure Agreements

    Non-disclosure agreements are a crucial, but often overlooked, tool in allowing startup companies to grow, build strategic partnerships and explore new business relationships necessary to develop their product or bring it to market. These agreements are often short (sometimes only a page or two) and lead many founders to forego legal advice to get past this "formality" and begin working with the other party to the NDA. Yet, NDAs are important agreements with potentially far-reaching implications for the protection of a company's confidential information and intellectual property, and mishandling of NDAs can come back to haunt a startup years later.
  • Advocates Eli Greenbaum and Ezra Gross of Yigal Arnon & Co. in The Lawyer Special Report editorial

    An interview-style piece in The Lawyer, Law in Israel: moving beyond tech, quoting Eli Greenbaum and Ezra Gross:
  • Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain

    Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain.
  • Article in MEA Markets on GDPR & Israeli Law

    GDPR & ISRAELI PRIVACY LAW - KEY DIFFERENCES Yoheved Novogroder-Shoshan & Miriam Friedmann of Yigal Arnon & Co. outline the key differences between GDPR & Israeli Privacy Law.  mea_markets_-_gdpr__israeli_law_-_key_differences_14.05.2018